Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1960 4
1961 3
1962 1
1963 2
1964 1
1965 5
1966 5
1967 5
1968 2
1969 1
1970 5
1971 8
1972 3
1974 5
1975 1
1976 3
1977 7
1978 7
1979 11
1980 3
1981 9
1982 8
1983 5
1984 13
1985 12
1986 14
1987 19
1988 15
1989 10
1990 14
1991 12
1992 14
1993 18
1994 19
1995 32
1996 14
1997 20
1998 20
1999 20
2000 18
2001 24
2002 30
2003 29
2004 30
2005 22
2006 29
2007 29
2008 24
2009 23
2010 27
2011 47
2012 42
2013 28
2014 25
2015 26
2016 42
2017 36
2018 48
2019 53
2020 51
2021 46
2022 51
2023 5
Text availability
Article attribute
Article type
Publication date

Search Results

1,069 results
Results by year
Filters applied: . Clear all
Page 1
CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer.
Ukita M, Hamanishi J, Yoshitomi H, Yamanoi K, Takamatsu S, Ueda A, Suzuki H, Hosoe Y, Furutake Y, Taki M, Abiko K, Yamaguchi K, Nakai H, Baba T, Matsumura N, Yoshizawa A, Ueno H, Mandai M. Ukita M, et al. Among authors: nakai h. JCI Insight. 2022 Jun 22;7(12):e157215. doi: 10.1172/jci.insight.157215. JCI Insight. 2022. PMID: 35552285 Free PMC article.
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA).
Hamanishi J, Takeshima N, Katsumata N, Ushijima K, Kimura T, Takeuchi S, Matsumoto K, Ito K, Mandai M, Nakai H, Sakuragi N, Watari H, Takahashi N, Kato H, Hasegawa K, Yonemori K, Mizuno M, Takehara K, Niikura H, Sawasaki T, Nakao S, Saito T, Enomoto T, Nagase S, Suzuki N, Matsumoto T, Kondo E, Sonoda K, Aihara S, Aoki Y, Okamoto A, Takano H, Kobayashi H, Kato H, Terai Y, Takazawa A, Takahashi Y, Namba Y, Aoki D, Fujiwara K, Sugiyama T, Konishi I. Hamanishi J, et al. Among authors: nakai h. J Clin Oncol. 2021 Nov 20;39(33):3671-3681. doi: 10.1200/JCO.21.00334. Epub 2021 Sep 2. J Clin Oncol. 2021. PMID: 34473544 Free PMC article. Clinical Trial.
AUTHOR REPLY.
Kawai S, Hyuga T, Nakamura S, Nakai H. Kawai S, et al. Among authors: nakai h. Urology. 2019 Feb;124:252-253. doi: 10.1016/j.urology.2018.06.065. Urology. 2019. PMID: 30784715 No abstract available.
Impending paradoxical embolism.
Henmi S, Nakai H, Yamanaka K, Omura A, Inoue T, Okada K. Henmi S, et al. Among authors: nakai h. J Cardiol Cases. 2020 Dec 4;24(1):20-22. doi: 10.1016/j.jccase.2020.11.021. eCollection 2021 Jul. J Cardiol Cases. 2020. PMID: 34257755 Free PMC article.
Direct Near Infrared Light-Activatable Phthalocyanine Catalysts.
Katsurayama Y, Ikabata Y, Maeda H, Segi M, Nakai H, Furuyama T. Katsurayama Y, et al. Among authors: nakai h. Chemistry. 2022 Jan 10;28(2):e202103223. doi: 10.1002/chem.202103223. Epub 2021 Dec 16. Chemistry. 2022. PMID: 34734432
1,069 results